entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 11:01:55 - browse：6

Sammy Kimball for STAT

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss what some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

For more on what we cover, here’s the news on Celsius Therapeutics; here’s more on EQRx; here’s the latest on Apellis Pharmaceuticals; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Drug repurposing or repositioning? The language matters
Next article： To avoid data mishandling cases, universities eye AI and other tools

WSS

For Medicare Advantage, Democrats want stronger protections around AI

For Medicare Advantage, Democrats want stronger protections around AI

Empower primary care with adequate payments and technology

Deliver public health messages at the right time

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Deliver public health messages at the right time

knowledge

entertainment

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Lawmakers grill UnitedHealth CEO on Change cyberattack

Affirmative action in medical school literally saved lives

Biden report: The neurospychology of memory and aging

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Senators start work on Medicare physician payment reform

Psychedelics group wrestles with new pharma identity

The creative science of coining drug names

Cancer drug shortages should be causing more outrage

Key House Republican on health care plans exit from Congress

hotspot

The creative science of coining drug names

Private equity deals in Medicare Advantage declines

How a small hospital in rural Puerto Rico survived Hurricane Maria

Lawmakers grill UnitedHealth CEO on Change cyberattack

Primary care doctor shortage won't be solved by free med school tuition

Deliver public health messages at the right time

focus

explore

hotspot

focus